Results of Rearrange Trial: A Randomized Phase 2 Study Comparing Different Dosing Approaches for Regoraferab (Reg) During the First Cycle of Treatment in Patients (Pts) with Metastatic Colorectal Cancer (Mcrc)
AuthID
P-00Q-VVF
P-00Q-VVF